title: Effect of rimonabant and metformin on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in obese women with polycystic ovary syndrome.
authors.forename: Thozhukat
authors.initials: T
authors.lastname: Sathyapalan
authors.forename: LiWei
authors.initials: L
authors.lastname: Cho
authors.forename: Eric S
authors.initials: ES
authors.lastname: Kilpatrick
authors.forename: Carel W
authors.initials: CW
authors.lastname: Le Roux
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Coady
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Atkin
mesh_terms: D004359:Drug Therapy, Combination; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000097:blood*; D052216:Glucagon-Like Peptide 1 / Q000097:blood*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008687:Metformin / Q000494:pharmacology / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D000077285:Rimonabant
chemical_list: D007004:Hypoglycemic Agents; D010880:Piperidines; D011720:Pyrazoles; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1; D008687:Metformin; D000077285:Rimonabant